BIOL BIOLASE, Inc.: Operating Margin

Corporate emblem and logo of Biolase Inc. (BIOL)

The medical innovation sector serves as a defensive asset with little dependence on global market fluctuations. Within this environment, BIOLASE, Inc. (BIOL) creates high-margin sales cycles for consumables. The EBIT margin demonstrates operational efficiency, where the value of -35.20 corresponds to the current metric. The integration of Waterlase systems into clinics eliminates the need for drilling, permanently locking dentists into the brand's technological ecosystem.

BIOL: BIOLASE Operating Margin 07/04/2022 - 08/04/2024

BIOLASE, Inc. - analytical breakdowns and key metrics (BIOL)

- share price and consensus valuation forecast:
Fundamental company analysis:BIOL, BIOLASE Inc.
Brand item of Biolase Inc.

The development of the razor-and-blade model in the sales of dental lasers and consumables directly determines the dynamics of the operating margin for BIOLASE, Inc. (BIOL). This indicator, calculated as the ratio of operating income to revenue, measures cost management efficiency before taxes and interest, allowing investors to assess the actual scalability of the business and promptly identify shifts in market sentiment.

Competitors of BIOLASE, Inc. (BIOL)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Return on Sales bioventus.com BVS|Operating Margin KIDS|TMCI - Operating Return on Sales|Operating Profitability Strata Critical Medical Inc SRTA|CARL: Return on Sales by Operating Profit|RXST: Operating Sales Margin|clearpointneuro.com - Operating Profit Ratio|Stereotaxis Inc (STXS) - Operating Profitability|Return on Sales by Operating Profit STIM|SGHT (Sight Sciences Inc) - Operating Margin|OBIO: Operating Profit Rate|Operating Margin ANIK|Profitability of Operations inspiremd.com|Jin Medical International - Operating Sales Margin|Operating Margin Vivani Medical, Inc. VANI|XTNT: Operating Sales Margin|Operating Return on Sales NeuroOne Medical Technologies Corp.|MODD: Operating Margin|MYO - Profitability of Operations|Operating Profitability Envoy Medical Inc.|VVOS (Vivos Therapeutics, Inc.) - Operating Profit Ratio|Operating Sales Margin NVNO (enVVeno)|SINT - Operating Return on Sales|Operating Margin TNON (Tenon Medical)|ReWalk Robotics Ltd. (LFWD) - Operating Return on Sales|AMIX: Operating Sales Margin|IVF: Operating Profitability|BBLG: Operating Margin|Operating Sales Margin Axonics, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)